-
The Jukebox Man on song as Redknapp records 'dream' King George win
-
Liverpool boss Slot says Ekitike reaping rewards for greater physicality
-
Judge jails ex-Malaysian PM Najib for 15 more years after new graft conviction
-
Musona rescues Zimbabwe in AFCON draw with Angola
-
Zelensky to meet Trump in Florida on Sunday
-
'Personality' the key for Celtic boss Nancy when it comes to new signings
-
Arteta eager to avoid repeat of Rice red card against Brighton
-
Nigeria signals more strikes likely in 'joint' US operations
-
Malaysia's former PM Najib convicted in 1MDB graft trial
-
Elusive wild cat feared extinct rediscovered in Thailand
-
Japan govt approves record budget, including for defence
-
Seoul to ease access to North Korean newspaper
-
History-maker Tongue wants more of the same from England attack
-
Australia lead England by 46 after 20 wickets fall on crazy day at MCG
-
Asia markets edge up as precious metals surge
-
Twenty wickets fall on day one as Australia gain edge in 4th Ashes Test
-
'No winner': Kosovo snap poll unlikely to end damaging deadlock
-
Culture being strangled by Kosovo's political crisis
-
Main contenders in Kosovo's snap election
-
Australia all out for 152 as England take charge of 4th Ashes Test
-
Boys recount 'torment' at hands of armed rebels in DR Congo
-
Inside Chernobyl, Ukraine scrambles to repair radiation shield
-
Bondi victims honoured as Sydney-Hobart race sets sail
-
North Korea's Kim orders factories to make more missiles in 2026
-
Palladino's Atalanta on the up as Serie A leaders Inter visit
-
Hooked on the claw: how crane games conquered Japan's arcades
-
Shanghai's elderly waltz back to the past at lunchtime dance halls
-
Japan govt approves record 122 trillion yen budget
-
US launches Christmas Day strikes on IS targets in Nigeria
-
Australia reeling on 72-4 at lunch as England strike in 4th Ashes Test
-
Too hot to handle? Searing heat looming over 2026 World Cup
-
Packers clinch NFL playoff spot as Lions lose to Vikings
-
Guinea's presidential candidates hold final rallies before Sunday's vote
-
Calvin B. Taylor Bankshares, Inc. Reports Third Quarter Financial Results and Announces New Stock Repurchase Program
-
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
-
Loar Holdings Inc. Announced The Completion of its Acquisition of LMB Fans & Motors
-
IRS Can Freeze Installment Agreements After Missed Filings - Clear Start Tax Explains Why Compliance Comes First
-
How the Terms of SMX's $111 Million Capital Facility Shape the Valuation Discussion
-
A Christmas Message to the DEA's Diversion Anti Marijuana Cabal
-
QAT Community Sets QuantumTrade 5.0 for Public Beta Testing in March 2026
-
BondwithPet Expands B2B Offering with Custom Pet Memorial Product
-
Best Crypto IRA Companies (Rankings Released)
-
Eon Prime Intelligent Alliance Office Unveils New Brand Identity and Completes Website Upgrade
-
Villa face Chelsea test as Premier League title race heats up
-
Spurs extend domination of NBA-best Thunder
-
Malaysia's Najib to face verdict in mega 1MDB graft trial
-
King Charles calls for 'reconciliation' in Christmas speech
-
Brazil's jailed ex-president Bolsonaro undergoes 'successful' surgery
-
UK tech campaigner sues Trump administration over US sanctions
Japan biochemist who discovered statins, Akira Endo, dies
Japanese biochemist Akira Endo, who discovered cholesterol-lowering statins, has died aged 90, his former student and colleague said on Tuesday.
Statins, which can prevent heart attacks or strokes, are among the most commonly prescribed drugs worldwide.
Keiji Hasumi, a professor who was a long-time associate of Endo, said the scientist had died on June 5.
"His work was truly great. Statins didn't exist before Endo," Hasumi told AFP. "It has the same value and impact as the discovery of penicillin."
Johns Hopkins Medicine says more than 200 million people take statins. Studies say the global market for them was worth $15 billion in 2023 and is expected to grow.
Endo experimented on thousands of microbes to reach his 1973 discovery of mevastatin -- an agent derived from penicillin that reduces so-called "bad" cholesterol in the blood.
The researcher "was a tough, strict person. He was insightful and perceptive," and "able to see the hidden essence of things", Hasumi said.
Endo was born in 1933 to a farming family in rural northern Japan.
His ambitions began early thanks to his grandfather, who was interested in medicine and became a "great home teacher", Endo said in a 2008 autobiographical essay.
As a student, Endo became interested in antibiotics like penicillin, "deeply impressed" by how many lives they had saved, his essay in the journal Nature Medicine said.
Endo carried out research in New York in the late 1960s, when coronary heart disease was the main cause of US deaths.
"I often saw ambulances coming to take elderly people who had suffered a heart attack to hospital", which "made me realise the importance of developing a cholesterol-lowering drug", he said.
Endo worked at the Tokyo University of Agriculture and Technology, which issued a statement expressing condolences over his death, and at Japanese drugmaker Sankyo, now a part of Daiichi-Sankyo.
He spent two years testing 6,000 strains of microbe in the search for a new drug that could help achieve his goal before finally finding mevastatin.
Conflicting reports on the benefits and potential harms of statins in recent years have prompted some people prescribed the drugs to stop taking them.
"Are statins safe? For most people, the answer is a resounding yes, according to a 2014 Johns Hopkins meta-analysis of 20 years worth of published research," the US university says.
Endo was a strong candidate for a Nobel Prize, but never won. In a report on his death, Japanese broadcaster NHK noted Endo had received other accolades, including being honoured as a Person of Cultural Merit by the government in 2011.
His discovery "was the result of many twists and turns", Hasumi said.
"He reached his goal by overcoming so many challenges, without which medicines cannot be created, I think I remember him saying."
Y.Kobayashi--AMWN